News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Gran Tierra launched a consent solicitation to amend its 9.75% Senior Secured Amortizing Notes due 2031.
  • Proposed amendments include collateral release tied to the planned sale of Swiss unit Gran Tierra Energy CI GmbH.
  • The changes also adjust accounting definitions to permit Maurel & Prom to assume debt obligations.
  • Noteholders will receive a consent fee for approving the amendments.
  • The sale would concentrate Gran Tierra's operations in Canada and Azerbaijan post-transaction.
  • The consent process aims to clear financing obstacles needed to complete the buyer transaction.

Latest Articles

SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

SciSparc Ltd.'s subsidiary NeuroThera Labs, in collaboration with Clearmind Medicine, has advanced their psychedelic drug pipeline with a newly published U.S. patent application covering a novel combination of MDMA and N-acylethanolamines (such as PEA) for the treatment of PTSD, anxiety, and eating disorders. This patent publication coincides with …

Callan JMB Retains Northern Oil and Gas Founder Michael Reger as President of Callan Power; Northern Oil and Gas Now Valued at Approximately $2.9 Billion

Callan JMB Retains Northern Oil and Gas Founder Michael Reger as President of Callan Power; Northern Oil and Gas Now Valued at Approximately $2.9 Billion

Callan JMB Inc. has appointed Michael Reger, founder and former CEO of Northern Oil and Gas, as President of its new subsidiary Callan Power LLC, focused on oil and gas resource development, energy resilience, and domestic manufacturing of critical electrical equipment. Leveraging Reger's extensive energy industry and public company leadership expe…

RCEL: RECELL Economics Make a Reimbursement-Driven Trade Case

RCEL: RECELL Economics Make a Reimbursement-Driven Trade Case

AVITA's RECELL platform is showing real-world evidence of shorter hospital stays and better healing that should appeal to payers. With a market cap near $300M and recent momentum, a measured long trade targets a re-rate as reimbursement improves. Key risks include legacy reimbursement backlogs, weak liquidity and elevated short interest.

BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval

BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval

BioCardia, a leader in cellular therapeutics for cardiovascular diseases, announced FDA confirmation of Pre-Submission Meeting minutes for its Helix Transendocardial Delivery Catheter. This ratification supports BioCardia's planned follow-on pre-submission intended to enable Helix's approval via the De Novo regulatory pathway, potentially accelerat…

Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851

Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851

Lexicon Pharmaceuticals has earned its third $10 million milestone payment in 2026 from Novo Nordisk following successful patient dosing in the Phase 1 trial of LX9851, a novel oral small molecule for obesity and metabolic disorders. This achievement brings total milestone payments to $75 million out of a potential $1 billion collaboration deal. Th…

La Rosa Holdings Corp. Reports First Half 2026 Results Highlighted by 10% Gross Profit Growth and 42% Improvement in Operating Loss

La Rosa Holdings Corp. Reports First Half 2026 Results Highlighted by 10% Gross Profit Growth and 42% Improvement in Operating Loss

La Rosa Holdings Corp., a US-based real estate and PropTech company, announced first half 2026 financial results marked by a nearly 10% increase in gross profit to $3.7 million and a 42% reduction in operating loss to $4.2 million compared to the prior year. The company also reported a 25% decrease in operating expenses and a 9.4% improvement in ne…

Expion Announces $9.0 Million Initial Closing of Private Placement

Expion Announces $9.0 Million Initial Closing of Private Placement

Expion Energy, Inc. announced the closing of a $9 million initial tranche of a private placement offering involving 8% Convertible Debentures and Warrants, with potential to raise an additional $91 million. The proceeds will be used to acquire oil and gas assets in Eastern Louisiana and for general corporate expenses. The company is broadening its …

EVA LIVE EXPANDS INTO GLOBAL GAMING MARKET PROJECTED TO EXCEED $200 BILLION THROUGH MAJORITY OWNERSHIP OF INTERNATIONAL GAMING ALLIANCE

EVA LIVE EXPANDS INTO GLOBAL GAMING MARKET PROJECTED TO EXCEED $200 BILLION THROUGH MAJORITY OWNERSHIP OF INTERNATIONAL GAMING ALLIANCE

Eva Live Inc. announces its 60% majority ownership of International Gaming Alliance (IGA), marking its strategic expansion into the global online gaming and lottery market. IGA has signed a three-year Master Services Agreement with Lottery.com International, enabling operations across multiple international territories. Eva Live will leverage its A…

New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026

New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026

Amarin Corporation plc announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2026 featuring new analyses from the REDUCE-IT trial and mechanistic EPA data. These presentations cover treatment adherence, long-term outcomes, and biomarker insights related to cardiovascular risk reduction with icosapent ethyl (VASCEPA/V…

Generac: Early Signs of a Commercial Recovery — Tactical Long Setup

Generac: Early Signs of a Commercial Recovery — Tactical Long Setup

Generac (GNRC) has shifted from a cyclical residential story toward commercial and industrial and data-center power solutions. Recent results and a large hyperscaler supply deal have reignited revenue growth and earnings beats. Valuation is not cheap, but improving fundamentals and supportive technicals set up a mid-term swing trade with defined ri…

Optical Stocks Retrace After Big Gains - Is This a Buying Window?

Optical Stocks Retrace After Big Gains - Is This a Buying Window?

The optical equipment group that outperformed earlier this year has reversed course sharply. Names including Coherent, Corning, Ciena and Lumentum have moved materially off their 52-week highs after hefty YTD gains driven by AI datacenter fiber demand. Technical indicators are bearish, fair value models still show premium valuations even after the …

Edible Garden and Square Roots Announce Strategic Partnership to Accelerate Farm-to-Formula® Functional Nutrition Platform

Edible Garden and Square Roots Announce Strategic Partnership to Accelerate Farm-to-Formula® Functional Nutrition Platform

Edible Garden AG, a Nasdaq-listed leader in controlled environment agriculture, announced a strategic partnership with Square Roots to develop a new generation of clean-label, functional ready-to-drink beverages. Combining Square Roots' expertise in plant science with Edible Garden's advanced Farm-to-Formula® platform and aseptic manufacturing, the…

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

Biogen and Eisai announced US availability of LEQEMBI IQLIK®, a subcutaneous autoinjector for initiation and maintenance therapy of early Alzheimer's disease, offering a more convenient and flexible alternative to intravenous infusion. The treatment, supported by robust clinical trial data demonstrating slowed disease progression and significant co…